A 64-year-old man with stage IV lung adenocarcinoma receives bevacizumab, carboplatin, and paclitaxel. Follow-up CT shows a newly developed cavity within the dominant lung mass, accompanied by a reduction in its overall size. Figure 1: Follow-up CT image from the referenced article. Reference: Cancer Imaging (scroll down to answer the question) ##Disclaimer## The content provided on Docplexus is intended for educational purposes only.

While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content from our industry partners. We do not associate with the views of any individual, community, organization, industry partner, or political party. Unauthorized use,…